🧠 This Week in Immunology: New Approvals & Breakthroughs in Autoimmune Treatment
Stay up to date with the latest immunology news, featuring exciting approvals and clinical trial results:
💥 Tremfya (Guselkumab) approved for Crohn’s Disease by the European Commission.
🏅 EULAR updates recommendations for antirheumatic drugs during pregnancy.
🤔 Arcutis’ Zoryve foam shows strong results for scalp and body psoriasis, with FDA review underway.
🌿 Icotrokinra demonstrates significant skin clearance in challenging psoriasis areas.
💉 Innovo Therapeutics reports promising Phase 1 results for INV-101 in autoimmune diseases.
🚀 Kymera’s KT-579 shows superior efficacy in preclinical models for autoimmune conditions.
Stay ahead in Immunology research!
✅ Like, share, and subscribe for weekly updates on the latest in Immunology and autoimmune diseases.
✅ Visit www.lqventures.com for expert healthcare insights and consulting services.
#Immunology #FDAApproval #PsoriasisTreatment #AutoimmuneResearch #HealthcareInnovations #CrohnsDisease #ClinicalTrials #ImmunologyNews